84 related articles for article (PubMed ID: 2627497)
1. Optimal conditions for the toxoiding of pertussis toxin with 1-ethyl-3(3-dimethylaminopropyl) carbodiimide.HCl.
Christodoulides M; Parton R; Stewart-Tull DE
FEMS Microbiol Immunol; 1989 Dec; 1(8-9):425-35. PubMed ID: 2627497
[TBL] [Abstract][Full Text] [Related]
2. Acellular pertussis vaccine prepared by a simple extraction and toxoiding procedure.
Christodoulides M; Sidey FM; Parton R; Stewart-Tull DE
Vaccine; 1987 Sep; 5(3):199-207. PubMed ID: 2890244
[TBL] [Abstract][Full Text] [Related]
3. A sensitive chemiluminescence assay for pertussis toxin and for evaluation of cell-free pertussis toxoids.
Craig FF; Christodoulides M; Parton R; Stewart-Tull DE; Freer JH; Lackie JM
FEMS Microbiol Immunol; 1988 Jul; 1(2):75-9. PubMed ID: 3273462
[TBL] [Abstract][Full Text] [Related]
4. [Inactivation and toxoiding of biologically-active components of Bordetella pertussis by tea catechins].
Watanabe M; Endoh M; Takeo T
Yakugaku Zasshi; 1998 Sep; 118(9):415-22. PubMed ID: 9779002
[TBL] [Abstract][Full Text] [Related]
5. Binding of DNA to albumin and transferrin modified by treatment with water-soluble carbodiimides.
Huckett B; Gordhan H; Hawtrey R; Moodley N; Ariatti M; Hawtrey A
Biochem Pharmacol; 1986 Apr; 35(8):1249-57. PubMed ID: 3964300
[TBL] [Abstract][Full Text] [Related]
6. Production of a safe, potent and immunogenic partially purified acellular pertussis vaccine using simple indigenous techniques.
Gupta RK; Saxena SN; Sharma SB; Ahuja S
Dev Biol Stand; 1991; 73():205-22. PubMed ID: 1778314
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.
Sato Y; Sato H
Tokai J Exp Clin Med; 1988; 13 Suppl():79-88. PubMed ID: 2908530
[TBL] [Abstract][Full Text] [Related]
8. [Effect of a water-soluble carbodiimide on the gating mechanism of "fast" sodium channels of the sensory neuron membrane of the rat].
Naumov AP; Neguliaev IuA; Vedernikova EA
Neirofiziologiia; 1987; 19(1):46-53. PubMed ID: 2437468
[TBL] [Abstract][Full Text] [Related]
9. Differential reactivity of active sites in human plasma cholinesterase toward 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide.
Ozer N; Ozer I
Arch Biochem Biophys; 1987 May; 255(1):89-94. PubMed ID: 3592672
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of skeletal-muscle UDP-glucose pyrophosphorylase by reaction with carboxylate-directed reagents.
Signorini M; Ferrari C; Mariotti E; Dallocchio F; Bergamini CM
Biochem J; 1989 Dec; 264(3):799-804. PubMed ID: 2559717
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of phosphate transport in human erythrocytes by water-soluble carbodiimides.
Craik JD; Reithmeier RA
Biochim Biophys Acta; 1984 Dec; 778(3):429-34. PubMed ID: 6336598
[TBL] [Abstract][Full Text] [Related]
12. The importance of reducing conditions for the inhibitory action of DBMIB+, antimycin A and EDAC+ on cyclic photophosphorylation.
Huber SC; Edwards GE
FEBS Lett; 1977 Jul; 79(1):207-11. PubMed ID: 891929
[No Abstract] [Full Text] [Related]
13. Characteristics and potency of an acellular pertussis vaccine composed of pertussis toxin, filamentous hemagglutinin, and pertactin.
Sheu GC; Wo YY; Yao SM; Chou FY; Hsu TC; Ju CL; Cheng Y; Chang SN; Lu CH
J Microbiol Immunol Infect; 2001 Dec; 34(4):243-51. PubMed ID: 11825003
[TBL] [Abstract][Full Text] [Related]
14. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
Vuolo AM; Lustigman B
Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
[TBL] [Abstract][Full Text] [Related]
15. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
Cyr T; Menzies AJ; Calver J; Whitehouse LW
Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
[TBL] [Abstract][Full Text] [Related]
16. Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
Yuen CT; Asokanathan C; Cook S; Lin N; Xing D
Vaccine; 2016 Apr; 34(18):2129-34. PubMed ID: 26973066
[TBL] [Abstract][Full Text] [Related]
17. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines.
Jensen SE; Illigen KE; Badsberg JH; Hasløv KR
Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164
[TBL] [Abstract][Full Text] [Related]
18. Carbodiimide crosslinking of human C1q and rabbit IgG.
Wines BD; Easterbrook-Smith SB
Mol Immunol; 1990 Mar; 27(3):221-6. PubMed ID: 2342486
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration.
Xing D; Das RG; Newland P; Corbel M
Vaccine; 2002 Oct; 20(29-30):3535-42. PubMed ID: 12297399
[TBL] [Abstract][Full Text] [Related]
20. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
